The Hamer Family
Participant Spotlight

The Hamer Family

As a nurse, Jessica Hamer was no stranger to type 1 diabetes (T1D) when her 4-year-old son Garrus started showing signs of the disease. She said, “I just kept thinking, it can’t be type 1.” But it was, and Garrus was diagnosed with the disease in the spring of 2017.

Read more
Dr. Jennifer McVean
Participant Spotlight

Dr. Jennifer McVean

Diagnosed with type 1 diabetes (T1D) at age 11, Jennifer McVean, MD, had not heard of TrialNet until she began working as a pediatric endocrinologist. Now, as part of the pediatric endocrinology team at University of Minnesota, Dr. McVean is a TrialNet advocate heavily involved in spreading the word about screening and studies.

Read more
The Maguire Family
Participant Spotlight

The Maguire Family

On the Frontline with the Maguire Family

The Maguire family is united in fighting the war on T1D. To participate in TrialNet research, they travel from Sault Ste. Marie, Ontario, to the Hospital for Sick Children at the University of Toronto every 6 months. That's a 7.5-hour drive, often through plenty of snow!

Read more
The Schuh Family
Participant Spotlight

The Schuh Family

When Jadah Schuh first heard about TrialNet screening at a JDRF Walk, she wanted to do it, but there was one problem: the blood draw. Several years and JDRF Walks would go by before, at age 8, she finally got screened at Camp Needlepoint, where her brother, Travis, was attending a T1D camp.

Read more
The Eyth Family
Participant Spotlight

The Eyth Family

Like many parents, AJ & Emily Eyth were worried about their daughters’ risk to develop type 1 diabetes because AJ lives with the disease. They learned about the TrialNet Pathway to Prevention risk screening offered at the University of South Florida and decided to enroll their daughters, Kacie & Kaley.

Read more
The Montgomery Family
Participant Spotlight

The Montgomery Family

Bridget Montgomery’s introduction to type 1 diabetes was when her son, Clifford, was diagnosed in DKA at the age of 6. It was at their initial type 1 diabetes training through Children’s Hospital of Pittsburgh that she learned about the opportunity to participate in TrialNet.

Read more
Elliot
Participant Spotlight

Elliot

Elliot, a 17-year-old from a small village outside Bristol, recently completed treatment in the Abatacept Prevention Study. He is the first person in the United Kingdom (UK) to do so.

Read more
Subscribe to Participant Spotlight